(Q48606930)

13 February 2018

title

Spasmodic dysphonia: onset, course, socioemotional effects, and treatment response (English)

1 reference

13 February 2018

1 reference

Kristine Tanner

1

1 reference

13 February 2018

Nelson Roy

2

1 reference

13 February 2018

Ray M Merrill

3

1 reference

13 February 2018

Cara Sauder

4

1 reference

13 February 2018

Daniel R Houtz

5

1 reference

13 February 2018

Marshall E Smith

6

1 reference

13 February 2018

publication date

1 July 2011

1 reference

13 February 2018

Annals of Otology Rhinology and Laryngology

number of pages

9

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

13 February 2018

volume

120

1 reference

13 February 2018

issue

7

1 reference

13 February 2018

page(s)

465-473

1 reference

13 February 2018

Symptom improvement of spastic dysphonia in response to phonatory tasks

cites work

1 reference

https://api.crossref.org/works/10.1177%2F000348941112000708

Focal white matter changes in spasmodic dysphonia: a combined diffusion tensor imaging and neuropathological study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000348941112000708

Acoustic measures of symptoms in abductor spasmodic dysphonia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000348941112000708

Treatment for spasmodic dysphonia: limitations of current approaches.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000348941112000708

Neuropathology of spasmodic dysphonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000348941112000708

Impact on quality of life of botulinum toxin treatments for spasmodic dysphonia and oromandibular dystonia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000348941112000708

Assessing the effectiveness of botulinum toxin injections for adductor spasmodic dysphonia: clinician and patient perception.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000348941112000708

Longitudinal effects of Botox injections on voice-related quality of life (V-RQOL) for patients with adductory spasmodic dysphonia: part II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000348941112000708

Recurrent laryngeal nerve section for spastic dysphonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000348941112000708

Adductor spastic dysphonia: three years after recurrent laryngeal nerve resection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000348941112000708

Bilateral thyroarytenoid denervation: a new treatment for laryngeal hyperadduction disorders studied in the canine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000348941112000708

Selective laryngeal adductor denervation-reinnervation: a new surgical treatment for adductor spasmodic dysphonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000348941112000708

Long-term follow-up results of selective laryngeal adductor denervation-reinnervation surgery for adductor spasmodic dysphonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000348941112000708

Spasmodic dysphonia and botulinum toxin: experience from the largest treatment series.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000348941112000708

Voice disorders in the general population: prevalence, risk factors, and occupational impact

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000348941112000708

Voice disorders in teachers and the general population: effects on work performance, attendance, and future career choices

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000348941112000708

Validation of an instrument to measure voice-related quality of life (V-RQOL).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000348941112000708

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000348941112000708

Research priorities in spasmodic dysphonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000348941112000708

Clinical practice guideline: hoarseness (dysphonia).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000348941112000708

Clinical characteristics of essential voice tremor: a study of 34 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000348941112000708

Clinical Subtypes of Essential Tremor

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000348941112000708

Interarytenoid muscle botox injection for treatment of adductor spasmodic dysphonia with vocal tremor

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000348941112000708

Risk factors and demographics in patients with spasmodic dysphonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000348941112000708

10.1177/000348941112000708

21 January 2018

Identifiers

DOI

1 reference

13 February 2018

1 reference

13 February 2018